NCT00136903 2022-01-31Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)Mesoblast, Ltd.Phase 2 Completed32 enrolled
NCT02953678 2021-11-24A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)Incyte CorporationPhase 2 Completed71 enrolled 24 charts 1 FDA
NCT00929695 2017-08-21Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host DiseaseFred Hutchinson Cancer CenterPhase 3 Completed164 enrolled 19 charts
NCT00004232 2012-06-01Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerNorthwestern UniversityPhase 1 Completed
NCT00357084 2010-09-14Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled
NCT00410657 2010-05-14Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled